Global Real-world evidence (RWE) Solutions market is estimated close to $1 billion (2020), growing at lucrative rate of ~15%. The Real-world evidence (RWE) solutions market growth is driven by rising support for RWE adoption from regulatory authorities, increased funding from pharma, and additional insights generated compared to randomized clinical trials (RCTs).